CC
BDSX icon

Chicago Capital’s Biodesix BDSX Stock Holding History

Chicago Capital’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,168
Closed -$38K – 234
2022
Q2 		$38K Hold
1,168
– – ﹤0.01% 236
2022
Q1 		$39K Sell
1,168
-180
-13% -$11.8K ﹤0.01% 251
2021
Q4 		$143K Buy
+1,348
New +$176K 0.01% 256

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Chicago Capital's BDSX Position: Q3 2022 in Review

Chicago Capital sold out of Biodesix (BDSX) in Q3 2022, closing a stake of 1,168 shares — an estimated $38K sold.

Chicago Capital first reported a position in BDSX in Q4 2021 and held it in 3 quarters. The position peaked at $143K in Q4 2021. 27 funds tracked by Wall St. Rank hold BDSX as of Q3 2022.

  • Chicago Capital reported no remaining Biodesix position as of Q3 2022 after selling out during the quarter.
  • Chicago Capital sold 1,168 Biodesix shares in Q3 2022, an estimated $38K.
  • Chicago Capital first reported a position in Biodesix in Q4 2021 and held it in 3 quarters.
  • Chicago Capital's Biodesix position peaked at $143K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Biodesix as of Q3 2022.

Based on Chicago Capital's 13F filing for Q3 2022, filed 14 Oct 2022.